Management of type 2 diabetes: Finding a sensible pathway through the maze of available agents

Drugs and Therapy Perspectives

Volumn 17, Issue 14, 2001, Pages 4-7

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBOHYDRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; LIPID; MEGLITINIDE; METFORMIN; MIGLITOL; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; VOGLIBOSE;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CLINICAL STUDY; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INDIVIDUALIZATION; KINESIOTHERAPY; LIFESTYLE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; POSTPRANDIAL STATE; RISK ASSESSMENT; SIDE EFFECT; TREATMENT INDICATION; TREATMENT PLANNING; UNITED KINGDOM; WEIGHT GAIN;

EID: 0035898386     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-200117140-00002     Document Type: Article

References (14)

1. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: The third national health and nutrition examination survey, 1988-1994
2. A rational approach to drug therapy of type 2 diabetes mellitus
3. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial
4. Implications of the UK Prospective Diabetes Study: Questions answered and issues remaining
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
7. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
8. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)
9. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years
10. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus
11. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
12. Sulfonylureas in NIDDM
13. Repaglinide
14. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes